A detailed history of F transactions in Novo Cure LTD stock. As of the latest transaction made, F holds 19,173 shares of NVCR stock, worth $217,038. This represents 0.01% of its overall portfolio holdings.

Number of Shares
19,173
Previous 34,560 44.52%
Holding current value
$217,038
Previous $615,000 59.84%
% of portfolio
0.01%
Previous 0.03%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025

SELL
$10.9 - $18.46 $167,718 - $284,044
-15,387 Reduced 44.52%
19,173 $247,000
Q2 2025

Aug 13, 2025

BUY
$15.37 - $19.4 $7,085 - $8,943
461 Added 1.35%
34,560 $615,000
Q1 2025

May 14, 2025

BUY
$17.82 - $30.19 $35,622 - $60,349
1,999 Added 6.23%
34,099 $607,000
Q4 2024

Feb 13, 2025

BUY
$14.54 - $33.41 $466,734 - $1.07 Million
32,100 New
32,100 $956,000

Others Institutions Holding NVCR

About NovoCure Ltd


  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $1.19B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track This Portfolio

Track F Portfolio

Follow F and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of F, based on Form 13F filings with the SEC.

News

Stay updated on F with notifications on news.